| Stage | DXPE | % of rev | MSM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $576M | 100.00% | $1.1B | 100.00% | MSM ×1.87 |
| Gross profit | $183M | 31.76% | $439M | 40.64% | MSM +8.9pp |
| Operating income | $55M | 9.63% | $73M | 6.75% | DXPE +2.9pp |
| Pre-tax income | $40M | 6.89% | $64M | 5.96% | DXPE +0.9pp |
| Net income | $29M | 4.98% | $48M | 4.44% | DXPE +0.5pp |
| Stage | DXPE | MSM | Gap · A − B |
|---|---|---|---|
| Revenue | $576M100.00% | $1.1B100.00% | MSM ×1.87 |
| Gross profit | 31.76%$183M | 40.64%$439M | MSM +8.9pp |
| Operating income | 9.63%$55M | 6.75%$73M | DXPE +2.9pp |
| Pre-tax income | 6.89%$40M | 5.96%$64M | DXPE +0.9pp |
None
No disclosed counterparties: DXPE.
| Net income |
| 4.98%$29M |
| 4.44%$48M |
| DXPE +0.5pp |